HomepageEarnings Events Newsdesk 7 minutes ago Alkermes plc (ALKS) Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 Alkermes plc (NASDAQ: ALKS) FY 2026 Other Release The PNC Financial Services Group, inc (PNC) PNC Private Bank Research Reveals Business Owners Increasingly Want Integrated Financial Advice to Help Align Business, Personal Goals » « Insulet Corporation (PODD) Q1 2026 Earnings Call Newsdesk:
